期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

重视螺内酯在难治性高血压中的应用

原文传递
导出
摘要 难治性高血压是指在改善生活方式的基础上，足量、足疗程（〉1月）应用了含利尿剂3种或3种以上的降压药物而血压仍不达标者。目前难治性高血压的患病率尚不明了，推算在5％～30％之间，有效控制难治性高血压可显著提高我国人群高血压达标率。
作者 周子华
机构地区 华中科技大学同济医学院附属协和医院心内科
出处 《医学新知》 CAS 2015年第6期369-370,共2页 New Medicine
关键词 难治性高血压 螺内酯
分类号 R544.1 [医药卫生—心血管疾病]
  • 相关文献

参考文献10

  • 1孙宁玲,霍勇,王继光,李南方,陶军,李勇,严晓伟,蒋雄京,李学旺.难治性高血压诊断治疗中国专家共识[J].中华高血压杂志,2013,21(4):321-326. 被引量：156
  • 2Weber M A, Schiin E L, White WB, et al. Clinical practice guide- lines for the management of hypertension in the community., a state- ment by the american society of hypertension and the international so-ciety of hypertension [ J ]. J Clin Hypertens (Greenwich) , 2014,6 (1) :14 -26.
  • 3Joel C Marts. Spironolactone Management of Resistant Hypertension [ J]. Ann Pharmacother,2010,44 : 1762-1769.
  • 4Jansen P M, Danser A H, Imholz B P, et al. Aldosterone -receptor antagonism in hypertension [ J ]. Journal of Hypertension, 2009,27 : 680-691.
  • 5GianLuca Colussi, Cristiana Catena, and Leonardo A. SechiSpirono- lactone,eplerenone and the new aldosterone blockers in endocrine and primary hypertension [ J ]. Journal of Hypertension, 2013,31 : 3- 15.
  • 6Nishisaka M K, Zaman, MA& Calhoun D A. Efficacy of low - dose spironolactone in subjects with resistant hypertension[ J ]. Am J tty- pertens ,2003,16:925-930.
  • 7de Souza F, Muxfeldt E, Fiszman R, et al. Efficacy of spironolactone therapy in patients with tree resistant hypertension [ J ]. Hyperten- sion,2010,55 ( 1 ) : 147-152.
  • 8Jan Va'clavik, Richard Sedla k, Martin Plachy, et al. Addition of Spi- ronolactone in Patients With Resistant Arterial Hypertension( ASPIR- ANT) : A Randomized, Double - Blind, Placebo - Controlled Trial [ J]. Hypertension ,2011,57 : 1069-1075.
  • 9Williams J S. Hypertension:spironolaetone and resistant hypertension [ J]. Nat Rev Endocrino1,2010 ,6 (5) :248-250.
  • 10Rosa J, Widimsk-, P, Tou-ek P, et al. Randomized comparison of re- nal denervation versus intensified pharmacotherapy includingspirono- lactone in true - resistant hypertension : six - month results from the prague - 15 study [ J ]. Hypertension,2015,65 (2) :407-413.

二级参考文献25

  • 1Calhoun DA, Jones D,Textor S,et al. Resistant hypertension:diagnosis, evaluation? and treatment. A scientific statement fromthe American Heart Association professional education committeeof the council for high blood pressure research[J]. Hypertension,2008,51(6):1403-1419.
  • 2Chobanian AV, Bakris GL, Black HR* et al; Joint national com-mittee on prevention,detection, evaluation, and treatment ofhigh blood pressure. National heart, lung, and blood institute;National high blood pressure education program coordinating com-mittee. Seventh report of the joint national committee on preven-tion, detection, evaluation, and treatment of high blood pressure[J]. Hypertension,2003,42(6) : 1206-1252.
  • 3Dahlof B,Sever PS, Poulter NR, et al. ASCOT Investigators.Prevention of cardiovascular events with an antihypertensive regi-men of amlodipine adding perindopril as required versus atenololadding bendroflumethiazide as required, in the Anglo-Scandinavi-an cardiac outcomes trial-blood pressure lowering arm(ASCOT-BPLA) : a multicentre andomized controlled trial[J].Lancet,2005,366(9489) :895-906.
  • 4Jamerson K, Weber MA, Bakris GL, et al. ACCOMPLISH trialinvestigators. Benazepril plus amlodipine or hydrochlorothiazidefor hypertension in high-risk patients[J]. N Engl J Med,2008,359(23):2417-2428.
  • 5Schmieder RE!, Redon J,Grassi G, et al. ESH position paper:renal denervation-an interventional therapy of resistant hyperten-sion[J]. J Hypertens,2012,30(5) :837-841.
  • 6Tsioufis C, Kordalis A,Flessas D,et al. Pathophysiology of re-sistant hypertension: the role of sympathetic nervous system[J].Int J Hypertens,2011 ;2011 :642416.
  • 7Barajas L,Liu L, Powers K. Anatomy of the renal innervation:intrarenal aspects and ganglia of origin [J]. Can J PhysiolPharmacol,1992,70(5) :735-749.
  • 8Hering D, Mahfoud F,Walton AS,et al. Renal denervation inmoderate to severe CKD[J]. J Am Soc Nephrol, 2012? 23 (27):1250-1257.
  • 9Laurent S,Schlaich M, Esler M. New drugs, procedures, anddevices for hypertension[J], Lancet,2012,380(9841) :591-600.
  • 10Aucott L,Poobalan A,Smith WC, et al. Effects of weight loss inoverweight/obese individuals and long-term hypertension outcomes : asystematic review[J], Hypertension,2005,45(6) : 1035-1041.

共引文献155

医学新知
2015年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部